So far, the number of deaths in the Seychelles attributed to the virus is relatively low — 28 out of more than 6,000 cases. But the surge in new cases may also confirm that the vaccines being used in the country have comparatively low effectiveness.
Roughly 60 percent of the doses administered in Seychelles are vaccines made by the Chinese company Sinopharm that were donated to the Seychelles by the United Arab Emirates. The remaining doses are of the vaccine developed by AstraZeneca and produced by the Serum Institute of India.
In many ways, Seychelles government negotiations for vaccine supplies were savvy and speedy. But the country has ended up using two vaccines that appear to be less effective against symptomatic covid-19.
The World Health Organization recently estimated the efficiency of the Sinopharm vaccine at just over 78 percent for adults under 60, with little data on its success with older patients.
Advertisement
Join the conversation as a VIP Member